TuisARX • ASX
add
Aroa Biosurgery Ltd
Vorige sluiting
$0,45
Dagwisseling
$0,43 - $0,46
Jaarwisseling
$0,35 - $0,82
Markkapitalisasie
151,76 m AUD
Gemiddelde volume
481,20 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
ASX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (NZD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 19,58 m | 22,86% |
Bedryfskoste | 19,45 m | 19,70% |
Netto inkomste | -1,65 m | 47,76% |
Netto winsgrens | -8,41 | 57,50% |
Wins per aandeel | — | — |
EBITDA | -1,62 m | 19,59% |
Effektiewe belastingkoers | -13,39% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (NZD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 21,90 m | -37,35% |
Totale bates | 105,68 m | -6,12% |
Totale aanspreeklikheid | 13,64 m | -11,64% |
Totale ekwiteit | 92,05 m | — |
Uitstaande aandele | 344,90 m | — |
Prys om te bespreek | 1,67 | — |
Opbrengs op bates | -5,83% | — |
Opbrengs op kapitaal | -6,22% | — |
Kontantvloei
Netto kontantverandering
| (NZD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -1,65 m | 47,76% |
Kontant van bedrywe | -2,43 m | 33,31% |
Kontant van beleggings | 3,90 m | 303,15% |
Kontant van finansiering | -360,50 k | -29,68% |
Netto kontantverandering | 1,04 m | 137,21% |
Beskikbare kontantvloei | -2,23 m | 25,95% |
Meer oor
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, USA and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward.
The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Gestig
2008
Webwerf
Werknemers
261
